Rick Gordon Named Halo Labs CEO – Proven 20 Year Track Record

Rick Gordon has been named Chief Executive Officer. He will assume day-to-day leadership of the Company and will also serve as a member of the Board of Directors.

Rick Gordon has 20 years of experience in the life science tools market and has held senior positions at ForteBio, Phasefocus, and Unchained Labs. Most recently, he served as the Vice President of Global Sales for Halo labs where he oversaw both sales and customer support. He lead the commercial launch of their popular Horizon® and Aura™ instruments, built a global sales and distribution network, and expanded Halo Labs’ customer base to include virtually every major global biopharmaceutical company.

“Rick has a proven track record and is the right leader for Halo Labs,” said Dr. Joe Keegan, Executive Chairman of Halo Labs. “He understands our customers and with Rick’s strategic vision, the company is in a great position to execute on the market opportunities ahead.”

Halo Labs is one of the most innovative companies in our industry and I’m excited about our future,” said Rick Gordon. “Thanks to the efforts of our team, our products have reduced therapeutic development timelines and have revolutionized stability testing across the industry. The Horizon and Aura systems have become the standard for high-throughput, low-volume particle analysis, and they are now considered the technology of choice in cell and gene therapy.”

 

Other Executives In the News

SourceHalo Labs
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy